{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:37:12Z","timestamp":1793911032957,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rmed.2026.109192","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:43:58Z","timestamp":1791330238000},"page":"109192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Scottish Airways Research Network (SARN) Delphi Consensus on pre-biologic assessment, clinical remission and post-remission management in severe asthma"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-9807","authenticated-orcid":false,"given":"Sunny","family":"Jabbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-949X","authenticated-orcid":false,"given":"Rekha","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1426-4544","authenticated-orcid":false,"given":"Philipp","family":"Suter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3807-0482","authenticated-orcid":false,"given":"Wai-Ting","family":"Nicola Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris RuiWen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-9041","authenticated-orcid":false,"given":"Douglas","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-9075","authenticated-orcid":false,"given":"Clare","family":"Ricketts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Embley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-7507","authenticated-orcid":false,"given":"Manish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Dobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euan","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5519-1288","authenticated-orcid":false,"given":"Alison","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Fardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2805-8266","authenticated-orcid":false,"given":"Rory","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.109192_bib1","series-title":"GINA Severe Asthma Guide","year":"2026"},{"issue":"1","key":"10.1016\/j.rmed.2026.109192_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4168\/aair.2026.18.1.19","article-title":"Precision medicine for asthma: tailored to its severity and endotype\/phenotype","volume":"18","author":"Chan","year":"2026","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109192_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00039-2016","article-title":"A multidisciplinary team case management approach reduces the burden of frequent asthma admissions","volume":"2","author":"Burke","year":"2016","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J. Methodol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eujim.2015.07.002","article-title":"Delphi methodology in health research: how to do it?","volume":"7","author":"Trevelyan","year":"2015","journal-title":"European Journal of Integrative Medicine"},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.125.4.1378","article-title":"Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma","volume":"125","author":"Bousquet","year":"2004","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2026.109192_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00413-2021","article-title":"Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma","volume":"58","author":"Kraft","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109192_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2019.08.050","article-title":"Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma","volume":"8","author":"Corren","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109192_bib18","unstructured":"Asthma: Diagnosis, Monitoring and Chronic Asthma Management (BTS, NICE, SIGN). https:\/\/www.nice.org.uk\/guidance\/ng245\/chapter\/Rationale-and-impact#medicine-combination-and-sequencing-in-people-aged-12-and-over-2 Date accessed July 28, 2026."},{"issue":"13","key":"10.1016\/j.rmed.2026.109192_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s41030-023-00234-y","article-title":"Triple therapy with Mometasone\/Indacaterol\/Glycopyrronium or doubling the ICS\/LABA dose in GINA step 4: IRIDIUM analyses","volume":"9","author":"van Zyl-Smit","year":"2023","journal-title":"Pulm Ther"},{"key":"10.1016\/j.rmed.2026.109192_bib21","first-page":"54","article-title":"Achieving clinical remission in moderate-to-severe asthma using inhaled triple therapy","author":"Canonica","year":"2026","journal-title":"ERJ Open Research"},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1164\/rccm.200411-1498OC","article-title":"Exhaled nitric oxide: a predictor of steroid response","volume":"172","author":"Smith","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.109192_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/all.70031","article-title":"Predictors of response to biologics for severe asthma: a systematic review and meta-analysis","volume":"81","author":"Rattu","year":"2026","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.rmed.2026.109192_bib24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jaci.2024.11.024","article-title":"Effects of dupilumab on mannitol airway hyperresponsiveness in uncontrolled severe asthma","volume":"155","author":"Stewart","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/all.70197","article-title":"The role of biologics in reducing mucous plug burden in asthma","volume":"81","author":"Poto","year":"2026","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.109192_bib27","article-title":"Biologics and airway remodeling in asthma: early, late, and potential preventive effects","author":"Varricchi","year":"2024","journal-title":"Allergy"},{"issue":"24","key":"10.1016\/j.rmed.2026.109192_bib28","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S2213-2600(24)00409-0","article-title":"Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials","volume":"13","author":"Bhatt","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"17","key":"10.1016\/j.rmed.2026.109192_bib30","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109192_bib31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2025.01.005","article-title":"Impact of smoking on biological treatment response in patients from the German severe asthma (GAN) registry","volume":"13","author":"Stoshikj","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"10.1016\/j.rmed.2026.109192_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaip.2023.10.012","article-title":"Tobacco exposure and efficacy of biologic therapy in patients with severe asthma: a nationwide study from the Danish severe asthma register","volume":"12","author":"Baastrup","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2026.109192_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ajrccm\/aamag473","article-title":"Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP","author":"Caminati","year":"2026","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109192_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02583-2021","article-title":"Asthma remission: what is it and how can it be achieved?","volume":"60","author":"Thomas","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2026.109192_bib35","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1164\/rccm.202012-4322LE","article-title":"FEV(1) minimum important difference versus minimal detectable difference? In search of the unicorn","volume":"203","author":"Crim","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib36","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2022.10.028","article-title":"Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma","volume":"151","author":"Chan","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2026.109192_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anai.2023.02.016","article-title":"Efficacy of biologic therapy on airway hyperresponsiveness in asthma","volume":"131","author":"Chan","year":"2023","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109192_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cea.70221","article-title":"New perspectives on effects of biologics on Mannitol Airway hyperresponsiveness","volume":"56","author":"Greig","year":"2026","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2026.109192_bib39","unstructured":"Lim JV, Lipworth B, Menzella F, et al. Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma. Ann. Allergy Asthma Immunol."},{"issue":"10423","key":"10.1016\/j.rmed.2026.109192_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2026.109192_bib41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109192_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.12.008","article-title":"The impact of dysfunctional breathing on the assessment of asthma control","volume":"123","author":"Veidal","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109192_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00404-2024","article-title":"OPTIMAL: titration of anti-IL5 biologics in severe asthma - an open label randomised controlled trial","author":"Soendergaard","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109192_bib44","doi-asserted-by":"crossref","DOI":"10.2147\/JAA.S567136","article-title":"Feasibility of a 50% dosing interval extension of Anti-IL-5 biologics in patients with severe asthma in clinical remission: a real-world validation study","volume":"19","author":"Vergles","year":"2026","journal-title":"J. Asthma Allergy"},{"issue":"7","key":"10.1016\/j.rmed.2026.109192_bib45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jaip.2025.05.031","article-title":"How to adjust asthma management once asthma is controlled on long-term biologic therapy","volume":"13","author":"Wechsler","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"7","key":"10.1016\/j.rmed.2026.109192_bib46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1542-3565(04)00238-1","article-title":"Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease","volume":"2","author":"Hanauer","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126005615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:12:26Z","timestamp":1793909546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126005615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0954611126005615"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109192","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scottish Airways Research Network (SARN) Delphi Consensus on pre-biologic assessment, clinical remission and post-remission management in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109192"}}